Eli Lilly Stock Jumps as Weight-Loss Drugs Fuel Sales
Wall Street Journal
The drugmaker reported strong second-quarter earnings and raised its outlook for the year amid the strong performance of Mounjaro and Zepbound. Shares rose 10% premarket.
https://www.wsj.com/articles/eli-lilly-stock-jumps-as-weight-loss-drugs-fuel-sales-8baf6e2e